Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platform
    • Strategy
    • Progress
    • Publications
  • Pipeline
    • Overview
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
Aug 04, 2020 7:35am EDT

Sonnet BioTherapeutics Announces At-The-Market Warrant Repricing and Exchange Resulting in Expected Gross Proceeds to the Company of up to $10.5 Million

Aug 04, 2020 7:30am EDT

Sonnet BioTherapeutics Signs Letter of Intent for Potential Licensing of Neuropathies Asset to New Life Therapeutics

Jul 20, 2020 7:30am EDT

Sonnet Biotherapeutics Announces Positive Preclinical Results from an Initial Efficacy Study Exploring the Combination of Granulocyte-Macrophage Colony-Stimulating Factor with Interleukins 18 and 12

Jul 15, 2020 7:30am EDT

Sonnet BioTherapeutics to Present at the 2020 BTIG Virtual Biotechnology Conference

May 18, 2020 7:30am EDT

Sonnet BioTherapeutics Holdings Provides Business and Earnings Update

Apr 06, 2020 7:30am EDT

Sonnet BioTherapeutics Announces Formation of Scientific Advisory Board

Apr 01, 2020 5:53pm EDT

Sonnet BioTherapeutics Holdings Announces Merger Closing

Feb 28, 2020 9:55am EST

Sonnet BioTherapeutics to Present at the 40th Annual Cowen Health Care Conference

Oct 22, 2019 9:28am EDT

Sonnet BioTherapeutics Selects Abzena as Clinical Stage Manufacturing Partner for its IL-12-FHAB cytokine-derived Therapeutic Candidate

Oct 10, 2019 4:05pm EDT

Chanticleer Holdings Announces Merger Agreement with Sonnet BioTherapeutics to Advance Pipeline of Novel Immune Therapeutics

RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    Next
    © 2023 Sonnet BioTherapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap